NickKholgh B, Fang X, Winters SM, Raina A, Pandya KS, Gyabaah K, Fino N, Balaji KC. Cell line modeling to study biomarker panel in prostate cancer. Prostate. 2016;76(3):245-258.
Li Z, Zhang C, Chen L, Li G, Qu L, Balaji KC, Du C. E-cadherin facilitates protein kinase D1 activation and subcellular localization. J Cell Physiol. 2016;():.
Gmeiner WH, Boyacioglu O, Stuart CH, Jennings-Gee J, Balaji KC. The cytotoxic and pro-apoptotic activities of the novel fluoropyrimidine F10 towards prostate cancer cells are enhanced by Zn(2+) -chelation and inhibiting the serine protease Omi/HtrA2. Prostate. 2015;75(4):360-369.
Fang X, Gyabaah K, Nickkholgh B, Cline JM, Balaji KC. Novel in vivo model for combinatorial fluorescence labeling in mouse prostate. Prostate. 2015;75(9):988-1000.
Balaji KC. Long-term survival rates after resection for locally advanced kidney cancer: Memorial Sloan Kettering Cancer Center 1989 to 2012 experience [editorial comment]. J Urol. 2015;193(6):1916-1917.
Balaji KC. Autophagy: friend or foe for progression and treatment of urothelial carcinoma [editorial]. J Urol. 2014;191(6):1644-1645.
Wicks EE, Fang XL, Balaji KC. Prorainbow: a novel in vivo prostate mouse model to track the origin of prostate cancer [abstract]. Tissue Eng Part A. 2014;20(Suppl 1):S139-S140.
Nickkholgh B, Fang XL, Gyabaah K, Balaji KC. Biological basis of aggressive phenotype in African-American prostate cancer cell line [abstract]. Cancer Res. 2014;74(19 Suppl):A4000.
Krane LS, Richards KA, Kader AK, Davis R, Balaji KC, Hemal AK. Preoperative neutrophil/lymphocyte ratio predicts overall survival and extravesical disease in patients undergoing radical cystectomy. J Endourol. 2013;27(8):1046-1050.
Fang X, Sittadjody S, Gyabaah K, Opara EC, Balaji KC. Novel 3D co-culture model for epithelial-stromal cells interaction in prostate cancer. PLoS One. 2013;8(9):e75187.
Fang XL, Sivanandane S, Gyabaah K Balaji KC. Novel 3D co-cultural model for epithelial-stromal cells interaction in prostate cancer [abstract]. Cancer Res. 2013;73(8 Suppl 1):A4078.
Balaji KC. Metastatic potential of a renal mass according to original tumour size at presentation [editorial comment]. BJU Int. 2012;109(2):194.
Du C, Zhang C, Li Z, Biswas MHU, Balaji KC. Beta-catenin phosphorylated at threonine 120 antagonizes generation of active beta-catenin by spatial localization in trans-Golgi network. PLoS ONE. 2012;7(4):e33830.
For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.
For a list of earlier publications, visit the Carpenter Library Publication Search.
Laparoscopic Surgery, Minimally Invasive Surgery, Robotic Urologic Surgery, Urologic Oncology
The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.
Before seeing my doctor I had an ultrasound of my kidneys. Everyone was professional, pleasant and attentive.
I trust Dr. BValaji implicity.
In my opinion: If *Dr. Baliji doesn't walk on water, he knows where the rocks are.
#9. High recommend to anyone! Excellent! #10. 110%.
Dr Balaji is one of the best physisicians I have ever worked with. He's knowledgeable, respectuful, empathetic, listens well, and explains clearly
Balaji is a superb physician - knowledgable, friendly, involved, and concerned
I would recommend Dr. Balaji for sure.
Total trust in the Doctor, Have Highly recommended him to other people that I know with the same issues I have.
Good news is always easy.......
Excellent doctor who is willing to take extra time with his patients if needed. I have total trust in his treatment of my problem.